Dr. Tina Sampalis Named Chief Scientific Officer Of Tersus Life Sciences

 BONITA SPRINGS, Fla., Feb. 29, 2016 /PRNewswire/ -- Tina Sampalis, M.D., PhD., has joined Tersus Life Sciences LLC ("Tersus"), as Chief Scientific Officer. Dr. Sampalis is an Oncology Surgeon and was trained in the fields of Physiology, Dermatology, and Pediatric General and Oncology Surgery.

Dr. Sampalis has Ph.D.'s in Surgical Research, Epidemiology and Experimental Surgery. Dr. Sampalis is a member of the American Association of Naturopathic Medicine and the named inventor of numerous omega-3 phospholipid composition and method patents, has authored numerous studies and peer-reviewed publications worldwide.

Dr. Sampalis has been named among 100 most successful women, globally, by the Princeton Global Network.

Dr. Sampalis joins Tersus Life Sciences following 15 years with Neptune Technologies and Bioresources as Chief Scientific Officer and President of Acasti Pharma. Dr. Sampalis discovered and successfully pioneered krill oil and her research demonstrated the advantages of krill oil omega-3 phospholipids, well recognized today by academia and worldwide markets. Dr. Sampalis is the catalyst for the success of such krill oil based products as Mega Red Krill Oil to global markets.

Dr. Sampalis will provide leadership, oversight and governance of Tersus' patent estate, present and future clinical studies, product innovations and global positioning of Tersus' Provinal® products. Provinal® Omega 7 is a naturally occurring highly purified monounsaturated fatty acid with a broad range of scientifically and clinically proven health indications, bridging the treatment gap in lipid management.

"I am very excited to work with innovative products and a company like Tersus, that recognizes and respects the importance of science and the value of a strong patent portfolio. I believe together, we will surprise the world once again with Provinal® Omega 7, an innovation that we can substantiate with clinical evidence and good science."

Timothy Gooding, Chairman of Tersus states, "We enthusiastically welcome Dr. Tina Sampalis to Tersus and we are excited to work with a world renowned expert in omega-3 phospholipid science, positioning Tersus in the forefront as an innovator in the field of monounsaturated fatty acids."

Tersus Life Sciences LLC ("Tersus"), is a US based bio-life science company dedicated to the research, development and commercialization of Provinal® Omega 7, a novel, patented and clinically substantiated monounsaturated fatty-acid ingredient targeting the prevention and reversal of dyslipidemia, and cardiometabolic disorders.


Connie Dease @ Tersus Life Sciences LLC 1.239.390.1226 [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dr-tina-sampalis-named-chief-scientific-officer-of-tersus-life-sciences-300226891.html

SOURCE Tersus Life Sciences LLC

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

U.K.-based alpha-synuclein biotech Wren will partner with Japanese pharma Eisai to seek out new ways of targeting neuro disorders.

As Moderna continues to drip-feed the latest data from its late-stage COVID-19 vaccine effort, it has updated the shot’s efficacy figure.

Two research teams have discovered drug combinations that may make it possible to translate CAR-T cell therapies to solid tumors.